Bio Farma / Kimia Farma
MedTech, BioTech & PharmaJakarta
Business focus
MedTech, BioTech & Pharma
Description
Bio Farma is Indonesia's state-owned pharmaceutical holding group, overseeing Kimia Farma and Indofarma. In 2026 Kimia Farma launched Stemxera, a stem-cell and secretome product developed since 2013 at the CPOB (GMP)-certified stem-cell laboratory of RSCM (Cipto Mangunkusumo Hospital), as part of the group's push into regenerative medicine and biotechnology.